Analysts expect Regeneron Pharmaceuticals, Inc. to report revenue of 4.64 B for Q3 26, against a range of 4.28 B to 5.01 B. The most recent reported quarter, Q2 26, came in at 4.29 B, a 6.9% beat against the 4.01 B consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.72 B | 3.79 B | 3.03 B | 3.68 B | 3.75 B | 3.88 B | 3.61 B | 4.29 B | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 3.64 B | 4.33 B | 3.77 B | 3.41 B | 3.49 B | 4.18 B | 3.59 B | 4.14 B | 5.01 B | 4.66 B | 4.62 B | 5.30 B | 5.43 B | 5.29 B | 5.03 B | 5.09 B | ||||||||||
| Low Estimate | 3.21 B | 3.67 B | 3.13 B | 2.93 B | 3.23 B | 3.87 B | 3.13 B | 3.89 B | 4.28 B | 4.30 B | 4.24 B | 4.34 B | 4.92 B | 4.62 B | 4.32 B | 4.45 B | ||||||||||
| Consensus Estimate | 3.43 B | 4.00 B | 3.45 B | 3.17 B | 3.36 B | 4.02 B | 3.36 B | 4.01 B | 4.64 B | 4.48 B | 4.43 B | 4.82 B | 5.18 B | 4.96 B | 4.68 B | 4.77 B |
Analysts expect Regeneron Pharmaceuticals, Inc. to report earnings per share of 14.89 for Q3 26, against a range of 14.05 to 15.73. The most recent reported quarter, Q2 26, came in at 14.29, a 37.4% beat against the 10.40 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 12.46 | 12.07 | 8.22 | 12.89 | 11.83 | 11.44 | 9.47 | 14.29 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 12.01 | 10.91 | 9.59 | 8.39 | 10.87 | 12.06 | 9.79 | 11.13 | 15.73 | 17.65 | 15.00 | 17.39 | 19.67 | 17.63 | 15.57 | 20.28 | ||||||||||
| Low Estimate | 10.29 | 10.23 | 8.81 | 7.61 | 9.37 | 10.06 | 8.81 | 9.67 | 14.05 | 15.01 | 12.76 | 15.31 | 16.83 | 16.17 | 12.81 | 16.98 | ||||||||||
| Consensus Estimate | 11.15 | 10.57 | 9.20 | 8.00 | 10.12 | 11.06 | 9.30 | 10.40 | 14.89 | 16.33 | 13.88 | 16.35 | 18.25 | 16.90 | 14.19 | 18.63 |
Pull Wall Street consensus for Regeneron Pharmaceuticals, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=REGN&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "REGN", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=REGN&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();